Pharma Pulse 1/14/25: Holding On Tight to AI Wave, the GLP-1 Landscape for Diabetes Care & more

Holding On Tight to AI Wave

The swell of AI-powered digital platforms puts future decision-making under the spotlight.

ASHP Midyear: Expert Discusses the GLP-1 Landscape for Diabetes Care

Pharmacy Times interviews Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, about glucagon-like peptide-1 receptors for diabetes treatment.

Biden Administration Adopts Rules to Guide AI’s Global Spread

New rules aim to keep advanced technology out of China and to ensure that cutting-edge artificial intelligence is developed by the United States and its allies.

Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth

Avanzanite Bioscience B.V. announced the appointment of Jason Cameron as Chief Technical Officer. This move marks a significant step in Avanzanite’s mission to accelerate growth, expand its presence in Europe, and advance the company’s next phase of international partnerships and product launches.

Applied Clinical Trials on LinkedIn

🎉 SCOPE Summit 2025: Don’t Miss Out! 🎉

Join 4,000+ clinical research professionals from 1,200+ organizations across 30 countries at the must-attend event for clinical trials and innovation!

📍 When & Where:
February 3-6, 2025 | Rosen Shingle Creek, Orlando, FL 🌴

✨ Why Attend?
30 conferences, including 3 new tracks
Focus on Decentralized Trials, Digital Health, AI, and more
Unmatched networking opportunities to connect and collaborate

💡 Special Offer: Save $200 with code ACT200!

🔗 Register now:https://lnkd.in/eZCa2i9W

#SCOPESummit #ClinicalTrials #Networking #Innovation

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs